rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
IPCA LABORATORIES LTD. - Ipca Laboratories Ltd reply to clarification sought by the exchange
< Back
26 Dec 2014
The Exchange has sought clarification from Ipca Laboratories Ltd with respect to news article appearing in Asian Age on December 25, 2014 titled &quot;DRL under health Canada Scanner&quot;&lt;BR&gt;&lt;BR&gt;Ipca Laboratories Ltd replied stating &quot;Wish to inform you that Health Canada has requested the Company to voluntarily quarantine any drugs manufactured at the Company&apos;s Indore SEZ, Pithampur formulations manufacturing unit intended for Canadian market as an interim measure and precautionary step in view of the US-FDA audit observations made regarding GMP deficiencies at the said manufacturing unit.&lt;BR&gt;&lt;BR&gt;The Company does not generate any material business out of the said manufacturing unit from the Canadian market.&lt;BR&gt;&lt;BR&gt;The Company is fully committed in resolving this issue at the earliest. The Company is also committed to its philosophy of highest quality in manufacturing, operations, systems, integrity and cGMP culture.&quot;
View all announcements for IPCA LABORATORIES LTD. Source: BSE India